ID   RN187_HUMAN             Reviewed;         235 AA.
AC   Q5TA31; A6NL57; Q6P2J7; Q6PJR0;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-MAY-2011, sequence version 2.
DT   10-MAY-2017, entry version 90.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF187;
DE            EC=2.3.2.27;
DE   AltName: Full=RING domain AP1 coactivator 1;
DE            Short=RACO-1;
DE   AltName: Full=RING finger protein 187;
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF187 {ECO:0000305};
GN   Name=RNF187;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, INTERACTION WITH JUN, SUBCELLULAR LOCATION, IDENTIFICATION
RP   OF A NON-AUG INITIATOR START CODON, UBIQUITINATION AT LYS-195; LYS-223
RP   AND LYS-224, AND MUTAGENESIS OF MET-1; CYS-12 AND CYS-15.
RX   PubMed=20852630; DOI=10.1038/ncb2098;
RA   Davies C.C., Chakraborty A., Cipriani F., Haigh K., Haigh J.J.,
RA   Behrens A.;
RT   "Identification of a co-activator that links growth factor signalling
RT   to c-Jun/AP-1 activation.";
RL   Nat. Cell Biol. 12:963-972(2010).
RN   [4]
RP   METHYLATION AT ARG-98 AND ARG-109, AND SUBUNIT.
RX   PubMed=23624934; DOI=10.1038/emboj.2013.98;
RA   Davies C.C., Chakraborty A., Diefenbacher M.E., Skehel M., Behrens A.;
RT   "Arginine methylation of the c-Jun coactivator RACO-1 is required for
RT   c-Jun/AP-1 activation.";
RL   EMBO J. 32:1556-1567(2013).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that acts as a coactivator
CC       of JUN-mediated gene activation in response to growth factor
CC       signaling via the MAP3K1 pathway, independently from MAPK8.
CC       {ECO:0000269|PubMed:20852630}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homodimer. Interacts with JUN, independently of JUN
CC       phosphorylation. {ECO:0000269|PubMed:20852630,
CC       ECO:0000269|PubMed:23624934}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20852630}.
CC       Nucleus {ECO:0000269|PubMed:20852630}. Note=Predominantly located
CC       in the cytoplasm. Shuttles between the cytoplasm and the nucleus.
CC   -!- DOMAIN: The RING-type zinc finger domain is required for E3 ligase
CC       activity.
CC   -!- PTM: Ubiquitinated; undergoes 'Lys-48'-linked autoubiquitination
CC       in the absence of growth factors and MAP3K1-induced 'Lys-63'-
CC       linked polyubiquitination. 'Lys-48'-autoubiquitination leads to
CC       degradation by the proteasome, while MAP3K1-induced 'Lys-63'-
CC       linked polyubiquitination results in the stabilization of the
CC       protein. 'Lys-48'- and 'Lys-63'-linked polyubiquitinations occur
CC       most probably on the same 3 C-terminal lysine residues (Lys-195,
CC       Lys-223 and Lys-224) and are thus mutually exclusive. Other sites
CC       of ubiquitination are not excluded. {ECO:0000269|PubMed:20852630}.
CC   -!- PTM: Arginine methylation by PRMT1 stabilizes RNF187 by
CC       facilitating K63-linked ubiquitin chain formation, and enables
CC       dimerization, c-Jun interaction and subsequent AP1 target gene
CC       expression. {ECO:0000269|PubMed:20852630,
CC       ECO:0000269|PubMed:23624934}.
CC   -!- CAUTION: This sequence initiates at a CTG codon.
CC       {ECO:0000305|PubMed:20852630}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH12758.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAH12758.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon.; Evidence={ECO:0000305};
CC       Sequence=CAI23328.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL139288; CAI23328.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC012758; AAH12758.1; ALT_SEQ; mRNA.
DR   EMBL; BC064481; AAH64481.1; -; mRNA.
DR   CCDS; CCDS76271.1; -.
DR   RefSeq; NP_001010858.2; NM_001010858.2.
DR   UniGene; Hs.356377; -.
DR   UniGene; Hs.679030; -.
DR   ProteinModelPortal; Q5TA31; -.
DR   BioGrid; 127223; 15.
DR   STRING; 9606.ENSP00000306396; -.
DR   iPTMnet; Q5TA31; -.
DR   PhosphoSitePlus; Q5TA31; -.
DR   DMDM; 332278146; -.
DR   EPD; Q5TA31; -.
DR   MaxQB; Q5TA31; -.
DR   PaxDb; Q5TA31; -.
DR   PeptideAtlas; Q5TA31; -.
DR   PRIDE; Q5TA31; -.
DR   Ensembl; ENST00000305943; ENSP00000306396; ENSG00000168159.
DR   GeneID; 149603; -.
DR   KEGG; hsa:149603; -.
DR   UCSC; uc057qfa.1; human.
DR   CTD; 149603; -.
DR   GeneCards; RNF187; -.
DR   H-InvDB; HIX0028697; -.
DR   HGNC; HGNC:27146; RNF187.
DR   HPA; HPA030098; -.
DR   MIM; 613754; gene.
DR   neXtProt; NX_Q5TA31; -.
DR   PharmGKB; PA142671058; -.
DR   eggNOG; ENOG410JC6A; Eukaryota.
DR   eggNOG; ENOG4111A5E; LUCA.
DR   HOGENOM; HOG000154159; -.
DR   HOVERGEN; HBG093909; -.
DR   InParanoid; Q5TA31; -.
DR   KO; K15709; -.
DR   OrthoDB; EOG091G0I4F; -.
DR   TreeFam; TF351093; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF187; human.
DR   GenomeRNAi; 149603; -.
DR   PRO; PR:Q5TA31; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000168159; -.
DR   CleanEx; HS_RNF187; -.
DR   Genevisible; Q5TA31; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IMP:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Isopeptide bond; Metal-binding;
KW   Methylation; Nucleus; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    235       E3 ubiquitin-protein ligase RNF187.
FT                                /FTId=PRO_0000278241.
FT   ZN_FING      12     53       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   MOD_RES      98     98       Asymmetric dimethylarginine; by PRMT1.
FT                                {ECO:0000269|PubMed:23624934}.
FT   MOD_RES     109    109       Asymmetric dimethylarginine; by PRMT1.
FT                                {ECO:0000269|PubMed:23624934}.
FT   CROSSLNK    195    195       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000305|PubMed:20852630}.
FT   CROSSLNK    223    223       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000305|PubMed:20852630}.
FT   CROSSLNK    224    224       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000305|PubMed:20852630}.
FT   MUTAGEN       1      1       M->A: Loss of protein expression.
FT                                {ECO:0000269|PubMed:20852630}.
FT   MUTAGEN      12     12       C->A: Increased RNF187 stability and
FT                                reduced polyubiquitination; when
FT                                associated with A-15.
FT                                {ECO:0000269|PubMed:20852630}.
FT   MUTAGEN      15     15       C->A: Increased RNF187 stability and
FT                                reduced polyubiquitination; when
FT                                associated with A-12.
FT                                {ECO:0000269|PubMed:20852630}.
FT   MUTAGEN     195    195       K->R: No detectable effect on
FT                                ubiquitination. Marked decrease in
FT                                ubiquitination, but on effect on
FT                                subcellular location; when associated
FT                                with R-223 and R-224.
FT   MUTAGEN     223    223       K->R: No detectable effect on
FT                                ubiquitination. Marked decrease in
FT                                ubiquitination, but on effect on
FT                                subcellular location; when associated
FT                                with R-195 and R-224.
FT   MUTAGEN     224    224       K->R: No detectable effect on
FT                                ubiquitination. Marked decrease in
FT                                ubiquitination, but on effect on
FT                                subcellular location; when associated
FT                                with R-195 and R-223.
SQ   SEQUENCE   235 AA;  26190 MW;  6C16442F7419CD25 CRC64;
     MALPAGPAEA ACALCQRAPR EPVRADCGHR FCRACVVRFW AEEDGPFPCP ECADDCWQRA
     VEPGRPPLSR RLLALEEAAA APARDGPASE AALQLLCRAD AGPLCAACRM AAGPEPPEWE
     PRWRKALRGK ENKGSVEIMR KDLNDARDLH GQAESAAAVW KGHVMDRRKK ALTDYKKLRA
     FFVEEEEHFL QEAEKEEGLP EDELADPTER FRSLLQAVSE LEKKHRNLGL SMLLQ
//
